Miscarriage (Types and Management)
Summary
Miscarriage is the spontaneous loss of pregnancy before viability, defined as before 24 weeks gestation in the UK (before 20 weeks in some countries). It affects 10-20% of clinically recognised pregnancies and is the most common complication of early pregnancy. The vast majority (80%) occur in the first trimester. Women presenting with vaginal bleeding in early pregnancy require careful assessment to determine the type of miscarriage, exclude ectopic pregnancy, and provide appropriate management. [1,2]
Key Facts
- Definition: Loss of pregnancy before 24 weeks gestation (UK) or before 20 weeks (USA).
- Incidence: 10-20% of clinically recognised pregnancies; higher if biochemical pregnancies included. [3]
- Recurrence: Single miscarriage = 20% risk next pregnancy; 3 consecutive = 30-40% risk.
- Timing: 80% occur in first trimester (less than 12 weeks).
- Cause: 50-60% are due to chromosomal abnormalities (primarily trisomies).
- Terminology: "Miscarriage" is the preferred patient-facing term; "spontaneous abortion" is clinical/ICD terminology.
Clinical Pearls
Rule Out Ectopic First: Before diagnosing any type of intrauterine miscarriage, you must determine pregnancy location. An "incomplete miscarriage" diagnosis is dangerous if the pregnancy is actually ectopic.
Cervical Shock: Products of conception impacted in the cervical os cause vagal stimulation → bradycardia, hypotension, pallor. Treatment is IMMEDIATE removal of products from the os with sponge forceps.
Empty Uterus = Not Reassurance: An empty uterus on ultrasound with a positive pregnancy test may be: complete miscarriage, ectopic pregnancy, or very early intrauterine pregnancy. Serial β-hCG and follow-up scan are essential.
Anti-D Immunoglobulin: Give to all Rh-negative women with threatened, inevitable, incomplete, or missed miscarriage greater than 12 weeks, or any surgical/medical management.
Incidence and Demographics
- Overall Miscarriage Rate: 10-20% of known pregnancies.
- Including Biochemical Losses: 30-50% of all conceptions.
- Age-Related Risk:
- Age 20-24: 9%
- Age 25-29: 10%
- Age 30-34: 12%
- Age 35-39: 18%
- Age 40-44: 34%
- Age 45+: 53% [4]
- Recurrent Miscarriage: Affects 1-2% of couples.
Risk Factors
| Risk Factor | Relative Risk | Notes |
|---|---|---|
| Maternal age greater than 35 | Progressive increase | Most significant risk factor |
| Previous miscarriage | 1.5-2x per previous loss | Cumulative effect |
| Smoking | 1.5x | Dose-dependent |
| Alcohol | Variable | Greater than 5 units/week increases risk |
| Caffeine | Modest increase | Greater than 200mg/day may increase risk |
| Obesity (BMI greater than 30) | 1.5-2x | Both spontaneous and recurrent |
| Antiphospholipid syndrome | 3-5x | Treatable cause |
| Uterine abnormalities | 2-3x | Septate uterus, fibroids |
| Poorly controlled diabetes | 2-3x | Well-controlled = minimal increased risk |
| Thyroid disease (untreated) | 2x | Hypo and hyperthyroidism |
Causes by Frequency
| Cause | Frequency | Notes |
|---|---|---|
| Chromosomal abnormalities | 50-60% | Trisomy (16 most common), triploidy, monosomy X |
| Unexplained | 25-30% | No identifiable cause |
| Uterine abnormalities | 10-15% | Septum, fibroids, Asherman's |
| Antiphospholipid syndrome | 5-15% (in recurrent) | Treatable |
| Endocrine | 5-10% | Thyroid, diabetes, PCOS |
| Infection | less than 5% | Rare cause |
Step 1: Normal Early Pregnancy Development
- Implantation: Blastocyst implants 6-7 days post-conception.
- Trophoblast Development: Produces β-hCG detected by 10 days.
- Gestational Sac: Visible on scan from 4-5 weeks.
- Yolk Sac: Visible from 5 weeks.
- Fetal Pole and Heartbeat: Visible from 6 weeks.
Step 2: Mechanisms of Pregnancy Loss
Chromosomal Abnormalities (Most Common)
- Random errors in meiosis (maternal or paternal).
- Trisomy 16 most common (not viable).
- Trisomies 21, 18, 13 may survive to later gestation or term.
- Triploidy (69 chromosomes) often presents as molar pregnancy or early loss.
Abnormal Placentation
- Shallow trophoblast invasion.
- Inadequate spiral artery remodelling.
- Leads to later losses and recurrent miscarriage.
Immunological Factors
- Antiphospholipid syndrome: Antibodies cause thrombosis in placental vessels.
- Natural killer cell dysfunction (controversial).
Uterine Factors
- Septate uterus: Poor vascularisation of septum.
- Fibroids: Submucous fibroids distort cavity.
- Asherman's syndrome: Intrauterine adhesions.
Step 3: Clinical Progression
- Fetal/Embryonic Demise: Developmental arrest or genetic abnormality.
- Hormonal Decline: β-hCG and progesterone begin falling.
- Uterine Response: Contractions, decidual breakdown.
- Bleeding and Expulsion: Products of conception expelled.
- Cervical Changes: Os opens during expulsion (inevitable/incomplete).
Types of Miscarriage - Summary Table
| Type | Bleeding | Pain | Cervix | Products | Fetal Viability | Management |
|---|---|---|---|---|---|---|
| Threatened | Mild | Mild/Absent | Closed | None passed | Viable (heartbeat+) | Reassure, follow-up |
| Inevitable | Heavy | Moderate | Open | Not yet expelled | Non-viable | Expectant/Medical/Surgical |
| Incomplete | Heavy | Cramping | Open | Partial | N/A | Medical/Surgical |
| Complete | Minimal | Resolved | Closed | Fully expelled | N/A | Confirm, support |
| Missed | Minimal/None | None | Closed | Retained | Confirmed non-viable | Expectant/Medical/Surgical |
| Septic | Variable | Severe | Variable | Infected | N/A | IV Antibiotics + Surgical |
Detailed Descriptions
Threatened Miscarriage
- Definition: Bleeding with viable intrauterine pregnancy.
- Presentation: Light vaginal bleeding, minimal pain, closed cervix.
- Ultrasound: Viable fetus (cardiac activity present).
- Prognosis: 50-75% continue to full-term delivery. [5]
- Management: Reassurance, avoid strenuous activity, follow-up scan in 1-2 weeks.
Inevitable Miscarriage
- Definition: Cervix is open, miscarriage will occur.
- Presentation: Heavy bleeding, significant cramping, os open.
- Ultrasound: Products in lower segment or cervix.
- Management: Cannot be prevented; expedite with medical or surgical management.
Incomplete Miscarriage
- Definition: Some products expelled, some retained.
- Presentation: Heavy bleeding, cramping, os may be open or closed.
- Ultrasound: Heterogeneous tissue greater than 15mm in endometrial cavity.
- Risk: Continued bleeding, infection.
- Management: Medical (misoprostol) or surgical (MVA/SMM).
Complete Miscarriage
- Definition: All products of conception expelled.
- Presentation: Bleeding settling, pain resolved, os closed.
- Ultrasound: Empty uterus or endometrial thickness less than 15mm.
- β-hCG: Declining.
- Management: Confirm completeness, emotional support, contraception.
Missed Miscarriage (Early Fetal Demise/Anembryonic Pregnancy)
- Definition: Non-viable pregnancy with retained products, no active bleeding.
- Types:
- Early Fetal Demise: Embryo present but no cardiac activity.
- Anembryonic Pregnancy: Gestational sac without embryo development.
- Presentation: Often asymptomatic; discovered on routine scan.
- Ultrasound Criteria (NICE):
- CRL greater than or equal to 7mm with no heartbeat.
- Mean sac diameter greater than or equal to 25mm with no embryo visible.
- Management: Expectant (2-3 week wait), medical, or surgical.
Septic Miscarriage
- Definition: Miscarriage complicated by uterine infection.
- Risk Factors: Retained products, unsafe abortion, instrumentation.
- Presentation: Fever, tachycardia, offensive vaginal discharge, uterine tenderness.
- Organisms: Polymicrobial; E. coli, anaerobes, Group A Strep.
- Management: IV broad-spectrum antibiotics + URGENT surgical evacuation.
History Taking
Gynaecological History
Current Symptoms
Risk Factors for Ectopic
Symptoms by Frequency
| Symptom | Frequency | Significance |
|---|---|---|
| Vaginal bleeding | 90% | First symptom in most cases |
| Abdominal cramping | 70% | Indicates uterine contractions |
| Passage of tissue | 30-40% | Confirms products expelled |
| Loss of pregnancy symptoms | Variable | Breast tenderness, nausea may reduce |
| Heavy bleeding | 20-30% | May indicate incomplete/inevitable |
| No symptoms | 20-30% | Missed miscarriage |
Red Flags - "The Don't Miss" Signs
- Cervical shock: Products in os with bradycardia, hypotension → remove products immediately.
- Heavy bleeding with haemodynamic instability → fluid resuscitation, urgent surgical.
- Fever, offensive discharge, tachycardia → septic miscarriage; antibiotics + surgery.
- Severe unilateral pain → ectopic until proven otherwise.
- Shoulder tip pain → haemoperitoneum from ruptured ectopic.
General Assessment
- Vital signs: Pulse, BP (assess for shock).
- Pallor, distress level.
- Temperature (fever suggests infection).
Abdominal Examination
- Tenderness (usually suprapubic).
- Uterine size (may be smaller than dates in missed miscarriage).
- Peritonism (suggests ectopic with bleeding).
Speculum Examination
Purpose
- Visualise cervix and os.
- Identify source of bleeding.
- Remove products from os if causing cervical shock.
Findings
| Observation | Significance |
|---|---|
| Os closed | Threatened, complete, or missed |
| Os open | Inevitable or incomplete |
| Products in os | Remove if causing shock |
| Blood from os | Active uterine bleeding |
| Offensive discharge | Septic miscarriage |
Bimanual Examination
- Cervical motion tenderness (think ectopic).
- Uterine size.
- Adnexal mass (ectopic, corpus luteum cyst).
First-Line Investigations
Urine Pregnancy Test
- Confirms pregnancy.
- Negative test with reported positive = ?complete miscarriage, ?false positive previously.
Serum β-hCG
- Quantitative level.
- Serial measurements (48 hours apart) if diagnosis unclear.
- Viable pregnancy: β-hCG rises by greater than 66% in 48 hours.
- Failing pregnancy: Suboptimal rise or falling values.
- Ectopic: Plateau or slow rise.
Transvaginal Ultrasound (TVUS)
- Gold standard for assessing early pregnancy.
- Determines pregnancy location and viability.
Ultrasound Criteria (NICE NG126)
Confirming Non-Viable Pregnancy (Definitive)
| Finding | Criteria |
|---|---|
| Crown-Rump Length (CRL) | Greater than or equal to 7mm with no heartbeat |
| Mean Sac Diameter (MSD) | Greater than or equal to 25mm with no embryo visible |
If Uncertain
- CRL less than 7mm with no heartbeat → repeat scan in minimum 7 days.
- MSD less than 25mm with no embryo → repeat scan in minimum 14 days.
Pregnancy of Unknown Location (PUL)
- Positive pregnancy test but no intrauterine or extrauterine pregnancy on scan.
- Serial β-hCG and repeat scan essential.
- May be: very early intrauterine pregnancy, complete miscarriage, or ectopic.
Blood Tests
| Test | Rationale |
|---|---|
| FBC | Hb if heavy bleeding |
| Blood group and antibody screen | Anti-D requirement |
| Coagulation | If heavy bleeding or sepsis |
| CRP/Lactate | If sepsis suspected |
Management Algorithm
SUSPECTED MISCARRIAGE
(Bleeding ± Pain in Early Pregnancy)
↓
┌─────────────────────────────────────────┐
│ EXCLUDE ECTOPIC FIRST │
│ - Risk factors? │
│ - TVUS + β-hCG │
└─────────────────────────────────────────┘
↓
TVUS FINDINGS
↓
┌─────────────────┼─────────────────┐
↓ ↓ ↓
VIABLE IUP NON-VIABLE IUP UNCERTAIN
↓ ↓ ↓
Threatened Discuss Repeat scan
Miscarriage Options in 7-14 days
↓ ↓
Reassure ┌───────┴───────┐
Follow-up ↓ ↓
INCOMPLETE/ MISSED
INEVITABLE MISCARRIAGE
↓ ↓
OPTIONS: OPTIONS:
┌────────┼────────┐ ┌────────┼────────┐
↓ ↓ ↓ ↓ ↓ ↓
Expectant Medical Surgical Expectant Medical Surgical
Management Options
1. Expectant Management ("Watchful Waiting")
- Principle: Allow natural expulsion of products.
- Suitable For: Stable, early pregnancy loss, patient preference.
- Duration: 7-14 days for incomplete; up to 4 weeks for missed.
- Success Rate: 50% at 7-14 days (incomplete); 25-50% (missed).
- Follow-Up: Urine pregnancy test in 3 weeks; scan if concerns.
- When to Intervene: Heavy bleeding, infection, patient request.
2. Medical Management
- Drug: Misoprostol (prostaglandin E1 analogue).
- Dose: 800μg PV or sublingual (can repeat if no effect in 24-48h).
- Mechanism: Induces uterine contractions, cervical ripening.
- Success Rate: 80-90% at 7 days. [6]
- Side Effects: Cramping, bleeding, nausea, diarrhoea.
- Analgesia: Prescribe strong analgesia (codeine/tramadol, NSAIDs).
- Follow-Up: Urine pregnancy test in 3 weeks.
3. Surgical Management
- Manual Vacuum Aspiration (MVA): Under local anaesthesia; outpatient.
- Surgical Management of Miscarriage (SMM): Under general anaesthesia; formerly "ERPC".
- Indications:
- Patient choice.
- Heavy bleeding/haemodynamic instability.
- Failed expectant or medical management.
- Septic miscarriage (urgent).
- Success Rate: greater than 99%.
- Risks: Uterine perforation (0.5%), cervical injury, incomplete evacuation, Asherman's (rare).
Management by Type
| Type | First-Line | Notes |
|---|---|---|
| Threatened | Reassurance, follow-up | No intervention needed |
| Inevitable | Expectant, Medical, or Surgical | Patient choice |
| Incomplete | Medical or Surgical | Expectant if minimal RPOC |
| Complete | Confirm, support | No intervention needed |
| Missed | Expectant, Medical, or Surgical | Longer expectant period acceptable |
| Septic | IV Antibiotics + URGENT Surgical | Never delay for medical management |
Anti-D Immunoglobulin
| Indication | Required? |
|---|---|
| Less than 12 weeks, no intervention | No |
| Greater than or equal to 12 weeks, any type | Yes (250 IU) |
| Any gestation with medical or surgical management | Yes |
| Heavy bleeding at any gestation | Yes |
Emotional Support
- Acknowledge loss; allow grieving.
- Offer written information.
- Provide contact for support services (e.g., Miscarriage Association).
- Offer follow-up appointment (1-2 weeks).
- Discuss when safe to try again (usually next cycle if ready).
Immediate Complications
| Complication | Incidence | Management |
|---|---|---|
| Heavy bleeding | 5-10% | IV access, fluids, urgent surgical if unstable |
| Cervical shock | Rare | Remove products from os, IV atropine if severe |
| Infection | 1-5% | Antibiotics ± surgical evacuation |
| Failed medical management | 10-20% | Surgical evacuation |
Surgical Complications
| Complication | Incidence | Prevention/Management |
|---|---|---|
| Uterine perforation | 0.5-1% | Experienced surgeon, ultrasound guidance |
| Cervical trauma | 0.5% | Gentle dilation |
| Incomplete evacuation | 2-5% | Repeat procedure if symptomatic |
| Asherman's syndrome | Rare | May affect future fertility |
Psychological Complications
- Grief and Loss: Normal; most resolve spontaneously.
- Anxiety in Future Pregnancies: 30-50%.
- Depression: 10-15% at 6 months.
- PTSD symptoms: 25% in some studies.
- Complicated Grief: May need specialist psychological support.
Prognosis After Single Miscarriage
- Risk of next pregnancy miscarriage: 20% (same as baseline).
- 85% of women will have successful subsequent pregnancy.
- No investigations or treatment needed after single miscarriage.
Prognosis After Recurrent Miscarriage (3+)
- Overall subsequent live birth rate: 60-75%.
- With antiphospholipid syndrome (treated): 70-80% success.
- Unexplained recurrent miscarriage: 75% success with supportive care only.
Time to Next Pregnancy
- WHO previously recommended 6-month wait (no evidence).
- Current evidence: Conception within 3 months of miscarriage has better outcomes than waiting longer. [7]
- Psychologically: Try when emotionally ready.
Follow-Up Recommendations
| Situation | Follow-Up |
|---|---|
| Single miscarriage | GP; no specialist referral |
| 2 consecutive miscarriages | Consider referral (varies by guideline) |
| 3+ consecutive miscarriages | Refer to recurrent miscarriage clinic |
| Late miscarriage (greater than 12 weeks) | Autopsy offered; specialist follow-up |
Key Guidelines
| Guideline | Organisation | Key Recommendations |
|---|---|---|
| NICE NG126 | UK | Ultrasound criteria, expectant as first option |
| RCOG Green-top 17 | UK | Recurrent miscarriage investigations |
| ESHRE Guideline | Europe | Recurrent pregnancy loss management |
| ACOG Practice Bulletin | USA | Early pregnancy loss definition and management |
Landmark Studies
1. MIST Trial (2006) [6]
- Question: Expectant vs medical vs surgical for incomplete/missed miscarriage?
- N: 1,200 women.
- Result: All three effective; no difference in infection or subsequent fertility.
- Impact: Established patient choice as central to management.
- PMID: 16627509.
2. Quenby et al. (2021) [8]
- Question: Does progesterone prevent miscarriage in threatened miscarriage?
- N: PRISM trial, 4,153 women.
- Result: Vaginal progesterone reduced miscarriage in women with previous losses; no benefit in those without.
- Impact: Progesterone offered to women with threatened miscarriage and history of loss.
- PMID: 33164751.
3. Love et al. (2010) [7]
- Question: Optimal interpregnancy interval after miscarriage?
- N: 30,937 women.
- Result: Conception within 6 months had lowest risk of subsequent miscarriage.
- Impact: No evidence to delay conception.
- PMID: 20688838.
4. PROMISE Trial (2015)
- Question: Does progesterone prevent recurrent miscarriage?
- N: 826 women with recurrent miscarriage.
- Result: No overall benefit (but subgroup may benefit).
- Impact: Progesterone not routine for recurrent miscarriage.
- PMID: 26586795.
What is a Miscarriage?
A miscarriage is the loss of a pregnancy before 24 weeks. Most happen in the first 12 weeks. Miscarriages are very common - about 1 in 5 confirmed pregnancies ends in miscarriage.
Why Does Miscarriage Happen?
- Most miscarriages (over half) happen because of chromosome problems in the developing baby that happened by chance.
- It is NOT caused by anything you did - exercise, work, sex, or stress do not cause miscarriage.
- Sometimes the cause is not known.
What Are the Warning Signs?
- Vaginal bleeding (spotting to heavy).
- Cramping or pain in your lower tummy or back.
- Passing tissue or clots.
- Pregnancy symptoms (nausea, breast tenderness) reducing suddenly.
What Happens Next?
If you have bleeding in early pregnancy, you may be offered:
- Ultrasound scan: To check if the pregnancy is healthy.
- Blood tests: To check pregnancy hormone levels.
- Follow-up scan: Sometimes a second scan is needed a week later to be certain.
How is Miscarriage Managed?
There are three options, and you can usually choose:
Expectant (Wait and Watch)
- Let your body pass the pregnancy naturally.
- Can take 1-4 weeks.
- You'll have a pregnancy test in 3 weeks to confirm it's complete.
Medical (Tablets)
- A tablet called misoprostol helps your body pass the pregnancy.
- Usually works within a few days.
- Causes cramping and bleeding.
Surgical
- A small procedure to remove the pregnancy tissue.
- Done under local or general anaesthetic.
- Quick and effective.
What About Future Pregnancies?
- Most women who have a miscarriage go on to have a healthy pregnancy next time.
- You can try again when you feel ready - there's no need to wait.
- If you have three miscarriages in a row, you may be referred for specialist tests.
When to Seek Urgent Help
- Very heavy bleeding (soaking more than 1 pad per hour).
- Severe pain.
- Fever or feeling very unwell.
- Dizziness or fainting.
- Shoulder tip pain (could indicate ectopic pregnancy).
Support
- The Miscarriage Association: miscarriageassociation.org.uk
- Tommy's: tommys.org
- Sands (if late miscarriage): sands.org.uk
Primary Sources
- NICE Guideline NG126. Ectopic pregnancy and miscarriage: diagnosis and initial management. 2019. https://www.nice.org.uk/guidance/ng126.
- ACOG Practice Bulletin No. 200. Early Pregnancy Loss. Obstet Gynecol. 2018;132:e197-e207. PMID: 30157093.
- Wilcox AJ, et al. Incidence of early loss of pregnancy. N Engl J Med. 1988;319:189-194. PMID: 3393170.
- Nybo Andersen AM, et al. Maternal age and fetal loss. BMJ. 2000;320:1708-1712. PMID: 10864550.
- Hasan R, et al. Association between first trimester vaginal bleeding and miscarriage. Obstet Gynecol. 2009;114:860-867. PMID: 19888046.
- Trinder J, et al. Management of miscarriage: expectant, medical, or surgical? BMJ. 2006;332:1235-1240. PMID: 16627509.
- Love ER, et al. Effect of interpregnancy interval on outcomes of pregnancy after miscarriage. BMJ. 2010;341:c3967. PMID: 20688838.
- Coomarasamy A, et al. A Randomized Trial of Progesterone in Women with Bleeding in Early Pregnancy. N Engl J Med. 2019;380:1815-1824. PMID: 33164751.
Medical Disclaimer: MedVellum content is for educational purposes and clinical reference. Clinical decisions should account for individual patient circumstances. Always consult appropriate specialists.